Etchin, J., Berezovskaya, A., Conway, A. S., Galinsky, I. A., Stone, R. M., Baloglu, E., . . . Look, A. T. (2017). KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells. Leukemia.
Citação norma ChicagoEtchin, J., et al. "KPT-8602, a Second-generation Inhibitor of XPO1-mediated Nuclear Export, Is Well Tolerated and Highly Active against AML Blasts and Leukemia-initiating Cells." Leukemia 2017.
Citação norma MLAEtchin, J., et al. "KPT-8602, a Second-generation Inhibitor of XPO1-mediated Nuclear Export, Is Well Tolerated and Highly Active against AML Blasts and Leukemia-initiating Cells." Leukemia 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.